DNTH
Dianthus Therapeutics Inc
NASDAQ · Biotechnology
$50.75
+4.17 (+8.95%)
Performance
1D
—
1W
-4.57%
1M
+29.73%
3M
+40.58%
6M
+143.41%
1Y
+117.72%
YTD
+27.90%
Open$47.57
Previous Close$46.58
Day High$51.44
Day Low$47.36
52W High$57.50
52W Low$13.37
Volume719.7K
Avg Volume943.1K
Market Cap2.19B
P/E Ratio—
EPS$-3.48
SectorBiotechnology
Volume Analysis
0.76x average volume
Technical Indicators
SMA 50
$44.48
Above
SMA 200
$30.84
Above
RSI (14)
63.2
Neutral
Trend
Golden Cross
Bullish
Analyst Ratings
Strong Buy
21 analysts
Price Target
-23.5% upside
Current
$50.75
$50.75
Target
$38.82
$38.82
$27.89
$38.82 avg
$53.79
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 8.09M | 305.72M | 270.76M |
| Net Income | -110,244,822 | -32,339,215 | -26,813,974 |
| Profit Margin | -1,362.8% | -10.6% | -9.9% |
| EBITDA | -132,759,731 | -32,605,970 | -27,281,394 |
| Free Cash Flow | — | -20,890,110 | -21,520,158 |
| Rev Growth | — | +9.7% | -3.3% |
| Debt/Equity | — | 0.57 | 0.83 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $223.43 | +2.01% | 165.4 | 394.89B |
| AMGN | Amgen Inc | $384.32 | +4.49% | 26.8 | 206.95B |
| GILD | Gilead Sciences Inc | $152.50 | +2.10% | 23.3 | 189.20B |
| VRTX | Vertex Pharmaceuticals Inc | $477.92 | +4.17% | 33.7 | 123.82B |
| REGN | Regeneron Pharmaceuticals | $785.51 | +2.46% | 18.4 | 83.03B |
| ALNY | Alnylam Pharmaceuticals Inc | $328.16 | -0.93% | 995.2 | 43.35B |